AKT1 and cancer: Despite molecular mechanisms underlying anticancer effects of statins in NETs are far to be fully elucidated, is it possible to assume a similarity with other cancers due to common signaling pathways, as in breast cancer cells, where simvastatin has been demonstrated to activate the ERK1/2 and Akt pathways, suppressing autophagy and promoting cell death [38].